Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

2.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplex Cytokine LTT Reveals Strong T Cell Responses to Multiple Drugs in NIDHR-Associated Multiple Drug Hypersensitivity.

The journal of allergy and clinical immunology. In practice·2026
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Molecular Characterization of Non-Specific Esophagitis Reveals a Distinct Non-Eosinophilic Phenotype With Fibrotic Traits.

Allergy·2026
Same author

An Immunologic Perspective on Adverse Reactions Observed Upon Systemic Therapies of Atopic Dermatitis: A Retrospective Study of 145 Cases.

Allergy·2026
Same author

Patch Test Results With the European Baseline Series, 2021/2022-Joint European Results of the ESSCA<sup>A</sup> and the EBS<sup>B</sup> Working Groups of the ESCD, and the GEIDAC<sup>C</sup>.

Contact dermatitis·2026
Same author

Contact sensitization in children and adolescents: Trends from a multicentre European study (2011-2022).

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same journal

Differences in Reported Anaphylaxis Associated With Common Nonsteroidal Anti-inflammatory Drugs: A Pharmacovigilance Study.

International archives of allergy and immunology·2026
Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
See all related articles

Related Experiment Video

Updated: Dec 21, 2025

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.8K

IL-15 Expression Pattern in Atopic Dermatitis.

Hélène Karlen1, Shida Yousefi2, Hans-Uwe Simon2,3

  • 1Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

International Archives of Allergy and Immunology
|May 19, 2020
PubMed
Summary
This summary is machine-generated.

Interleukin-15 (IL-15) is elevated in atopic dermatitis (AD) skin, appearing in keratinocytes, dendritic cells, macrophages, and fibroblasts. This suggests IL-15 could be a therapeutic target for AD.

Keywords:
Atopic dermatitisDendritic cellFibroblastInterleukin 15Keratinocyte

More Related Videos

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.0K
Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

12.5K

Related Experiment Videos

Last Updated: Dec 21, 2025

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.8K
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

15.0K
Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
08:49

Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

Published on: May 28, 2021

12.5K

Area of Science:

  • Immunology
  • Dermatology
  • Cell Biology

Background:

  • Interleukin-15 (IL-15) is a cytokine crucial for immune cell stimulation, implicated in various inflammatory and autoimmune conditions.
  • Atopic dermatitis (AD) is a prevalent inflammatory skin disorder associated with a type 2 immune response.

Purpose of the Study:

  • To investigate the expression and localization patterns of IL-15 within the skin of individuals with atopic dermatitis.
  • To compare IL-15 expression in lesional AD skin, nonlesional AD skin, and normal skin.

Main Methods:

  • Immunofluorescence staining was employed on skin biopsies from AD patients (lesional and nonlesional) and healthy controls.
  • Antibodies targeting IL-15 and various immune and structural cell markers (CD3, mast cell tryptase, eosinophil cationic protein, CD68, CD11b, CD1a, vimentin) were utilized.

Main Results:

  • Significantly higher IL-15 expression was detected in both the epidermis and dermis of AD and nonlesional AD skin compared to normal skin.
  • IL-15 expressing cells included keratinocytes, CD1a+ dendritic cells (DCs), CD11b+ DCs, CD68+ macrophages, and vimentin+ fibroblasts.
  • AD skin showed an increased relative number of IL-15 expressing CD1a+ DCs, macrophages, and fibroblasts.

Conclusions:

  • The expression pattern of IL-15 in atopic dermatitis skin resembles that observed in other type 2 immune diseases like eosinophilic esophagitis.
  • Interleukin-15 presents a potential therapeutic target for the management of atopic dermatitis.